Tauriga Sciences, Inc. Enters into Confidential Settlement Agreement and General Releases in Connection with the Action Against its Former Auditors

NEW YORK, NY -- (Marketwired) -- 11/10/17 -- On November 09, 2017 (the "Effective Date"), Tauriga…

Continue Reading

Tauriga Sciences, Inc. Obtains Stockholders Approval to Increase its Authorized Common Stock at Special Shareholder Meeting

NEW YORK, NY -- (Marketwired) -- 06/28/17 -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or…

Continue Reading

Tauriga Sciences, Inc. Receives Notification from DTCC That the Company has Been Approved for DWAC Services

NEW YORK, NY -- (Marketwired) -- 01/27/17 -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or…

Continue Reading

CORRECTION – Tauriga Sciences, Inc. Sells Majority Stake of Pilus Energy Subsidiary to Open Therapeutics LLC

NEW YORK, NY -- (Marketwired) -- 12/28/16 -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or…

Continue Reading

Tauriga Sciences, Inc. Sells Majority Stake of Pilus Energy Subsidiary to Open Therapeutics LLC

NEW YORK, NY -- (Marketwired) -- 12/27/16 -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or…

Continue Reading

Tauriga Sciences, Inc. Enhances Its Corporate Governance Protocols Through the Establishment of Four Board Oversight Committees and Corporate Code of Ethics

NEW YORK, NY -- (Marketwired) -- 04/26/13 -- Tauriga Sciences, Inc. (OTCQB: TAUG) ("the Company"), a…

Continue Reading